Original Report

Utilization of radiotherapy services by a palliative care unit: pattern and implication


 

Background The role of radiotherapy in palliation is well recognized. Analyzing referrals from an inpatient palliative care unit to the radiation oncology service may help in planning palliative care services and educational programs.

Objective To determine the pattern and rate of referrals from a PCU to the RO service at a tertiary oncology facility in Saudi Arabia.

Methods Referrals from the PCU to the RO service were prospectively identified over the period beginning November 27, 2007 and ending March 9, 2011. The appropriateness of referrals was determined by 2 radiation oncologists.

Results Of the 635 cancer admissions to the PCU, 25 (3.9%) referrals to RO were made, and 32 sites were irradiated. All patients had a poor performance status (ECOG 3). The most common areas irradiated were vertebrae (40.6%), pelvis (18.7%) and other bony structures (28.1%). Pain control was the most frequent reason for referral (87.5%). Only one referral was regarded by the RO service as inappropriate, indicating that 96% of the referrals were appropriate. The mean time lapse between referral and starting radiation was 4 3.6 days. A total of 75% of the patients died in the PCU within a median of 30 days post radiotherapy.

Conclusion The small minority of patients in the PCU referred for radiotherapy were deemed appropriate referrals by the radiation oncologists despite their poor performance status and limited time remaining. When planning a PCU with similar admission criteria, the availability of a radiotherapy facility in close proximity may not be a priority.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Surviving breast cancer shouldn't mean relinquishing intimacy
Breast Cancer ICYMI
Late Leukemia Risk Rises after Breast Cancer Therapy
Breast Cancer ICYMI
Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32
Breast Cancer ICYMI
A randomized, double-blind, placebo-controlled study of oral coenzyme Q 10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer
Breast Cancer ICYMI
What's in a name: Is the moniker 'palliative care' too loaded?
Breast Cancer ICYMI
Dexamethasone eases end-of-life cancer-related fatigue
Breast Cancer ICYMI
USPSTF draft recommendations update chemoprevention for breast cancer
Breast Cancer ICYMI
Treatment patterns in HER2-/HR-positive postmenopausal women with metastatic breast cancer initiating first-line treatment in a community oncology setting in the US
Breast Cancer ICYMI
Weight loss, exercise can impact cancer incidence and recurrence
Breast Cancer ICYMI
Resistance exercise interventions during and following cancer treatment: a systematic review
Breast Cancer ICYMI